---
schema_version: "secwatch.filing_event.v1"
accession: "0001412408-23-000095"
form_type: "8-K"
ticker: "PHR"
cik: "0001412408"
company_name: "Phreesia, Inc."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:40:59.055132+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Phreesia appoints Dr. Lisa Egbuonu-Davis to Board and adopts 2023 Inducement Award Plan

## Summary
- Appointed Dr. Lisa Egbuonu-Davis as Class II director effective July 13, 2023, to serve until 2024 annual meeting.
- Received pro-rated annual RSU grant valued at $177,418, vesting on the earlier of one year or next annual meeting.
- Received additional new hire RSU grant valued at $185,000 with a four-year graded vesting schedule.
- Board adopted 2023 Inducement Award Plan reserving 500,000 shares for grants to new employees and executives.

## SEC filing metadata
- accession: 0001412408-23-000095
- form_type: 8-K
- ticker: PHR
- cik: 0001412408
- company_name: Phreesia, Inc.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000095/0001412408-23-000095-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000095/phr-20230713.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001412408-23-000095
- JSON: https://secwatch.observer/filing/0001412408-23-000095.json
- Plain text: https://secwatch.observer/filing/0001412408-23-000095.txt

## Key facts
- Executive change
  Dr. Lisa Egbuonu-Davis was appointed as Director at Phreesia, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 13, 2023, the Board of Directors (the "Board") of Phreesia, Inc. (the "Company"), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Lisa Egbuonu-Davis to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000095/0001412408-23-000095-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.